Study Published in the Journal of Medicinal Chemistry Shows TAE Life Sciences’ BTS Drug Offers Many Advantages Over BPA for BNCT Use

The team at TAE Life Sciences is thrilled to unveil groundbreaking research that could transform the landscape of cancer care. A recent study, focusing on TAE Life Sciences’ Boronotyrosine (BTS) drug, a novel borylated amino acid analogue, has demonstrated exceptional potential to elevate the effectiveness of BNCT in combating cancer.